Literature DB >> 19298319

Do genetic and individual risk factors moderate the efficacy of motivational enhancement therapy? Drinking outcomes with an emerging adult sample.

Sarah W Feldstein Ewing1, Heather A LaChance, Angela Bryan, Kent E Hutchison.   

Abstract

Research indicates that motivational enhancement therapy (MET) helps catalyze reductions in problem drinking among emerging adults. However, moderators of this intervention remain relatively unknown. Therefore, the objectives of this study were: (1) to test whether a single session of MET increased motivation to reduce drinking and drinking outcomes; and (2) to examine whether genetic dopamine D(4) receptor L (DRD4 L) and individual personality risk factors (impulsivity and novelty seeking) moderated the effects of the MET. These hypotheses were evaluated by randomly assigning a sample of emerging adult problem drinkers (n = 67) to receive a single session of MET or alcohol education. Follow-up data indicated that only individuals who were low in impulsivity, novelty seeking and/or who had the short DRD4 variable number of tandem repeats genotype evidenced differentially increased behavior change (taking steps toward reducing drinking) following the MET.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19298319      PMCID: PMC2913542          DOI: 10.1111/j.1369-1600.2009.00149.x

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  51 in total

1.  Effects of a brief motivational intervention with college student drinkers.

Authors:  B Borsari; K B Carey
Journal:  J Consult Clin Psychol       Date:  2000-08

2.  Brief intervention for harm reduction with alcohol-positive older adolescents in a hospital emergency department.

Authors:  P M Monti; S M Colby; N P Barnett; A Spirito; D J Rohsenow; M Myers; R Woolard; W Lewander
Journal:  J Consult Clin Psychol       Date:  1999-12

Review 3.  Anticipating clinical integration of pharmacogenetic treatment strategies for addiction: are primary care physicians ready?

Authors:  A E Shields; C Lerman
Journal:  Clin Pharmacol Ther       Date:  2008-03-05       Impact factor: 6.875

4.  DNA by mail: an inexpensive and noninvasive method for collecting DNA samples from widely dispersed populations.

Authors:  B Freeman; J Powell; D Ball; L Hill; I Craig; R Plomin
Journal:  Behav Genet       Date:  1997-05       Impact factor: 2.805

5.  Simple non-invasive method to obtain DNA for gene analysis.

Authors:  N Lench; P Stanier; R Williamson
Journal:  Lancet       Date:  1988-06-18       Impact factor: 79.321

6.  Olanzapine reduces craving for alcohol: a DRD4 VNTR polymorphism by pharmacotherapy interaction.

Authors:  Kent E Hutchison; Angela Wooden; Robert M Swift; Andrew Smolen; John McGeary; Lawrence Adler; Lyndee Paris
Journal:  Neuropsychopharmacology       Date:  2003-10       Impact factor: 7.853

7.  Neurogenetic adaptive mechanisms in alcoholism.

Authors:  C R Cloninger
Journal:  Science       Date:  1987-04-24       Impact factor: 47.728

8.  Motivational enhancement therapy for high-risk adolescent smokers.

Authors:  Amy Helstrom; Kent Hutchison; Angela Bryan
Journal:  Addict Behav       Date:  2007-03-07       Impact factor: 3.913

9.  An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study.

Authors:  Raymond F Anton; Gabor Oroszi; Stephanie O'Malley; David Couper; Robert Swift; Helen Pettinati; David Goldman
Journal:  Arch Gen Psychiatry       Date:  2008-02

10.  The incentive salience of alcohol: translating the effects of genetic variant in CNR1.

Authors:  Kent E Hutchison; Heather Haughey; Michelle Niculescu; Joe Schacht; Alan Kaiser; Jerry Stitzel; William J Horton; Francesca Filbey
Journal:  Arch Gen Psychiatry       Date:  2008-07
View more
  32 in total

1.  A randomized controlled trial of a behavioral economic supplement to brief motivational interventions for college drinking.

Authors:  James G Murphy; Ashley A Dennhardt; Jessica R Skidmore; Brian Borsari; Nancy P Barnett; Suzanne M Colby; Matthew P Martens
Journal:  J Consult Clin Psychol       Date:  2012-06-04

2.  The structure of the UPPS-R-Child impulsivity scale and its relations with substance use outcomes among treatment-seeking adolescents.

Authors:  Rachel L Tomko; James J Prisciandaro; Sandhya Kutty Falls; Viktoriya Magid
Journal:  Drug Alcohol Depend       Date:  2016-02-15       Impact factor: 4.492

3.  Neurocognitive performance, alcohol withdrawal, and effects of a combination of flumazenil and gabapentin in alcohol dependence.

Authors:  Joseph P Schacht; Patrick K Randall; L R Waid; Alicia M Baros; Patricia K Latham; Tara M Wright; Hugh Myrick; Raymond F Anton
Journal:  Alcohol Clin Exp Res       Date:  2011-06-01       Impact factor: 3.455

4.  Charting a course for genomic medicine from base pairs to bedside.

Authors:  Eric D Green; Mark S Guyer
Journal:  Nature       Date:  2011-02-10       Impact factor: 49.962

5.  How psychosocial alcohol interventions work: a preliminary look at what FMRI can tell us.

Authors:  Sarah W Feldstein Ewing; Francesca M Filbey; Amithrupa Sabbineni; Lindsay D Chandler; Kent E Hutchison
Journal:  Alcohol Clin Exp Res       Date:  2011-01-11       Impact factor: 3.455

Review 6.  Pharmacogenetics of alcohol and alcohol dependence treatment.

Authors:  Henry R Kranzler; Howard J Edenberg
Journal:  Curr Pharm Des       Date:  2010       Impact factor: 3.116

Review 7.  Topical Review: The Emerging Field of Epigenetics: Informing Models of Pediatric Trauma and Physical Health.

Authors:  Nicole R Nugent; Amy Goldberg; Monica Uddin
Journal:  J Pediatr Psychol       Date:  2015-03-29

Review 8.  Application of Research Domain Criteria to childhood and adolescent impulsive and addictive disorders: Implications for treatment.

Authors:  Sarah W Yip; Marc N Potenza
Journal:  Clin Psychol Rev       Date:  2016-11-09

9.  Impulsivity as a moderator of the intention-behavior relationship for illicit drug use in patients undergoing treatment.

Authors:  Samantha J Moshier; Matthew Ewen; Michael W Otto
Journal:  Addict Behav       Date:  2012-09-12       Impact factor: 3.913

10.  A preliminary examination of how serotonergic polymorphisms influence brain response following an adolescent cannabis intervention.

Authors:  Sarah W Feldstein Ewing; Hilary K Mead; Uma Yezhuvath; Sam Dewitt; Kent E Hutchison; Francesca M Filbey
Journal:  Psychiatry Res       Date:  2012-11-30       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.